UNC0638

Catalog No.S8071 Batch:S807102

Print

Technical Data

Formula

C30H47N5O2

Molecular Weight 509.73 CAS No. 1255580-76-7
Solubility (25°C)* In vitro DMSO 100 mg/mL (196.18 mM)
Water Insoluble
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description UNC0638 is a potent, selective and cell-penetrant chemical probe for G9a and GLP histone methyltransferase with IC50 of <15 nM and 19 nM, respectively, shows selectivity over a wide range of epigenetic and non-epigenetic targets. UNC0638 has anti-viral activities.
Targets
G9a [1]
(Cell-free assay)
GLP [1]
(Cell-free assay)
<15 nM 19 nM
In vitro UNC0638 is a potent, selective and cell-penetrant chemical probe for G9a and GLP, with a toxicity/function ratio of >100, compared to <6 for BIX01294. UNC0638 is a selectivite inhibitor of G9a and GLP over a wide range of epigenetic and non-epigenetic targets. UNC0638 is more than 10,000-fold selective against SET7/9 (a H3K4 HMTase), SET8 (a H4K20 HMTase), PRMT3, and SUV39H2. In MDA-MB-231 cells, UNC0638 (48 h exposure) reduces H3K9me2 levels in a concentration-dependent manner with an IC50 of 81 nM. UNC0638 treatment of a variety of cell lines results in lower global H3K9me2 levels, equivalent to levels observed for small hairpin RNA knockdown of G9a and GLP with the functional potency of UNC0638 being well separated from its toxicity. UNC0638 markedly reduces the clonogenicity of MCF7 cells, reduces the abundance of H3K9me2 marks at promoters of known G9a-regulated endogenous genes and disproportionately affected several genomic loci encoding microRNAs. In mouse embryonic stem cells, UNC0638 reactivates G9a-silenced genes and a retroviral reporter gene in a concentration-dependent manner without promoting differentiation. [1]
In vivo In mouse drug metabolism and pharmacokinetic studies, UNC0638 had high clearance, short half-life, high volume distribution and low exposure after intravenous, oral or intraperitoneal administration. Thus, although UNC0638 is probably not suitable for in vivo animal studies owing to low exposure levels, its high stability under cellular assay conditions, in combination with high potency and selectivity, makes UNC0638 an ideal chemical tool for cell-based studies[1].

Protocol (from reference)

Kinase Assay:

[1]

  • SAHH-coupled assays

    This assay utilizes SAHH to hydrolyze the methyltransfer product S-adenosylhomocysteine to homocysteine and adenosine in the presence of adenosine deaminase which converts adenosine to inosine. The homocysteine concentration is then determined through conjugation of its free sulfhydryl moiety to a thiol-sensitive fluorophore, ThioGlo. For IC50 determinations, assay mixtures are prepared in 25 mM Potassium Phosphate buffer pH 7.5, 1 mM EDTA, 2 mM MgCl2, 0.01% Triton X 100 with 5 μM SAHH , 0.3 U/mL of adenosine deaminase, 25 μM SAM, and 15 μM ThioGlo. G9a, EHMT1, SETD7, SETD8, PRMT3 and SUV39H2 are assayed at 25 nM, 100 nM, 200 nM, 250 nM, 1 μM and 100 nM, respectively. UNC0638 is added at concentrations ranging from 4 nM to 16 μM. After 2 min incubation, reactions are initiated by addition of the histone peptides: 10 μM H3(1-25) for G9a, 20 μM H3(1-25) for EHMT1, 100 μM H3(1-25) for SETD7, 500 μM H4(1-24) for SETD8, 10 μM H4(1-24) for PRMT3 and 200 μM H3K9Me1 (1-15) for SUV39H2. The methylation reaction is followed by monitoring the increase in fluorescence using Biotek Synergy2 plate reader with 360/40 nm excitation filter and 528/20 nm emission filter for 20 min in 384 well-plate format. Activity values are corrected by subtracting background caused by the peptide or the protein. IC50 values are calculated using Sigmaplot. Standard deviations are calculated from two independent experiments.

Cell Assay:

[1]

  • Cell lines

    MCF7, U2OS, H1299 cell lines

  • Concentrations

    3 μM

  • Incubation Time

    65 h

  • Method

    Approximately 5×105 cells were plated onto 75 cm2 flasks. MCF7 and U2OS cells were grown in Minimal Essential Media (MEM) without phenol red supplemented with Earl's salts, 10% FBS, 1 mM Pyruvate, 2 mM Glutamine, and 1×non-essential amino acids. H1299 cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) with phenol red supplemented with 10% FBS and 1×Anti-Anti. At the time of cell plating, media was supplemented with 3 μM UNC638A or the equivalent DMSO vehicle. The media with 3 μM UNC638A but without any cells was also used as a control. All flasks were incubated at 37℃/5% CO2. After 65 hours, media was collected from the cells and centrifuged to remove any cell debris. The media (10 to 15 mL) from each of study groups was mixed with HPLC grade chloroform (7 to 12 mL). After the mixture was gently shaken, it was allowed to sit until the organic layer and the aqueous layer separated. The organic layer was collected, dried over anhydrous Na2SO4, and concentrated in vacuo. The resulting residue was dissolved in 100 μL of methanol and the solution was analyzed using an Agilent 6110 LC/MS Series system with UV detector set to at 254 nm. Samples were injected (10 μL) onto a Phenomenex Kinetex 2.1 x 100 nm, 2.6 μM, C18 column at room temperature and eluted with 72% B (MeCN) with A being H2O + 0.1% formic acid. The flow rate was 0.3 mL/min. No degradation products of UNC0638 were observed for any of treatment groups.

Animal Study:

[1]

  • Animal Models

    Swiss albino mice

  • Dosages

    IV, 1 mg/kg; PO, 3 mg/kg; IP, 2.5 mg/kg

  • Administration

    i.v./i.p./oral

Selleck's UNC0638 has been cited by 15 publications

The ARID1A-METTL3-m6A axis ensures effective RNase H1-mediated resolution of R-loops and genome stability [ Cell Rep, 2024, 43(2):113779] PubMed: 38358891
Transcriptome-based chemical screens identify CDK8 as a common barrier in multiple cell reprogramming systems [ Cell Rep, 2023, 42(6):112566] PubMed: 37235474
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses [ Cancer Cell, 2022, 40(10):1190-1206.e9] PubMed: 36179686
Influenza A virus NS1 protein hijacks YAP/TAZ to suppress TLR3-mediated innate immune response [ PLoS Pathog, 2022, 18(5):e1010505] PubMed: 35503798
Epigenetic Dysregulation Induces Translocation of Histone H3 into Cytoplasm [ Adv Sci (Weinh), 2021, e2100779] PubMed: 34363353
Histone Methyltransferase G9a Promotes the Development of Renal Cancer through Epigenetic Silencing of Tumor Suppressor Gene SPINK5 [ Oxid Med Cell Longev, 2021, 2021:6650781] PubMed: 34336110
Synergistic Anti-Tumor Effect of Combining Selective CDK7 and BRD4 Inhibition in Neuroblastoma [ Front Oncol, 2021, 11:773186] PubMed: 35198433
HeLa TI cell-based assay as a new approach to screen for chemicals able to reactivate the expression of epigenetically silenced genes [ PLoS One, 2021, 16(6):e0252504] PubMed: 34115770
TBC1D3 promotes neural progenitor proliferation by suppressing the histone methyltransferase G9a [ Sci Adv, 2021, 7(3)eaba8053] PubMed: 33523893
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection. [ Nat Commun, 2020, 11(1):604] PubMed: 32001678

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.